Gujarat Themis Biosyn Ltd
Gujarat Themis Biosyn Ltd Share Price Today: Live Updates & Key Insights
Get insights on Gujarat Themis Biosyn Ltd’s fundamentals, financials, shareholding, peer comparison, corporate actions & performance. Track key metrics, price trends & market sentiment for informed decisions. Explore all data at Motilal Oswal.
Gujarat Themis Biosyn Ltd Share Price Chart
Gujarat Themis Biosyn Ltd Fundamentals
Traded Volume: 1,26,360
Market Cap(Cr): 4,497
Avg Traded Price 415.30
1 Year return %
Upper Circuit 423.1
Lower Circuit 406.4
P/E TTM 93.00
P/B Ratio 4.00
Traded Value(Cr) 521.49
EPS TTM 4.432
Book value 4.432
Dividend 0.00%
Gujarat Themis Biosyn Ltd Share Price Performance
Shows the percentage change in stock price over different time periods
This section highlights Gujarat Themis Biosyn Ltd stock price performance across key timeframes, including 1-week, 1-month, 3-month, Year-To-Date (YTD), and 1-year returns. It provides insights into the Gujarat Themis Biosyn Ltd share price history, short-term movements, long-term trends, and overall investor sentiment
1W -8.25%
1M -8.82%
3M +7.08%
1Y null%
YTD null%
Gujarat Themis Biosyn Ltd Traded Volume Movement
Shows the trading volume over different time periods
This section highlights Gujarat Themis Biosyn Ltd daily and average traded volumes, offering insights into investor activity and market liquidity. Higher volumes than average often indicate rising interest, news impact, or shifting market sentiment
Yesterday 77046.00
Day Before Yesterday 3.01L
1W Avg 94072.00
1M Avg 1.41L
3M Avg 2.10L
Gujarat Themis Biosyn Ltd Technical Details
Gujarat Themis Biosyn Ltd technical indicators, such as support and resistance levels and pivot points, are calculated based on historical price and volume trends. These metrics help traders anticipate possible price movements and make informed trading decisions.
Support 1 406
Support 2 399
Support 3 391
Pivot Point : 415
Resistance 1 422
Resistance 2 430
Resistance 3 437
Gujarat Themis Biosyn Ltd Corporate Actions
Gujarat Themis Biosyn Ltd corporate actions include dividends, bonus issues, stock splits, and key company updates that may affect share price and investor sentiment. This section provides timely details on past and upcoming actions, including ex-date, record date, and payout ratio - helping investors make informed decisions based on Gujarat Themis Biosyn Ltd’s capital allocation strategies.
All
Ex-Date 04-Sep-2025 Type D Description 0.67/share@67.00% Record Date 05-Sep-2025 Ratio 67.00
Ex-Date 09-Aug-2024 Type B Description share@1:2 Record Date 09-Aug-2024 Ratio 1:2
Ex-Date 15-Jul-2024 Type D Description 0.25/share@25.00% Record Date - Ratio 25.00
Ex-Date 22-Feb-2024 Type D Description 0.75/share@75.00% Record Date 22-Feb-2024 Ratio 75.00
Ex-Date 10-Oct-2023 Type S Description share@1:5.00 Record Date 10-Oct-2023 Ratio 1:5.00
Ex-Date 01-Sep-2023 Type D Description 1.00/share@20.00% Record Date - Ratio 20.00
Ex-Date 01-Dec-2022 Type D Description 4.40/share@88.00% Record Date 02-Dec-2022 Ratio 88.00
Ex-Date 29-Aug-2022 Type D Description 4.00/share@80.00% Record Date - Ratio 80.00
Ex-Date 24-Nov-2021 Type D Description 5.00/share@100.00% Record Date 25-Nov-2021 Ratio 100.00
Ex-Date 24-Nov-2021 Type D Description 2.00/share@40.00% Record Date 25-Nov-2021 Ratio 40.00
Ex-Date 10-Sep-2020 Type D Description 1.65/share@33.00% Record Date - Ratio 33.00
Dividends
Announcement Date 04-Sep-2025 Ex Dividend Date 04-Sep-2025 Dividend(%) 67
Announcement Date 15-Jul-2024 Ex Dividend Date 15-Jul-2024 Dividend(%) 25
Announcement Date 22-Feb-2024 Ex Dividend Date 22-Feb-2024 Dividend(%) 75
Announcement Date 01-Sep-2023 Ex Dividend Date 01-Sep-2023 Dividend(%) 20
Announcement Date 01-Dec-2022 Ex Dividend Date 01-Dec-2022 Dividend(%) 88
Announcement Date 29-Aug-2022 Ex Dividend Date 29-Aug-2022 Dividend(%) 80
Announcement Date 24-Nov-2021 Ex Dividend Date 24-Nov-2021 Dividend(%) 100
Announcement Date 24-Nov-2021 Ex Dividend Date 24-Nov-2021 Dividend(%) 40
Announcement Date 10-Sep-2020 Ex Dividend Date 10-Sep-2020 Dividend(%) 33
Bonus
Record Date 09-Aug-2024 Ex-Bonus Date 09-Aug-2024 Ratio 1:2
Splits
Record Date 10-Oct-2023 Split Date 10-Oct-2023 Face Value (Before/After) 5.00/1.00
Others
Rights No Rights has been declared by GUJTHEM
Gujarat Themis Biosyn Ltd Peer Comparison
Shows key financial metrics for the company and its peers
This section compares Gujarat Themis Biosyn Ltd with leading peers in the banking sector based on key metrics such as market capitalization, 1-year return, P/E (TTM), and PB ratio. It helps investors evaluate Gujarat Themis Biosyn Ltd's relative performance and valuation against major competitors.
Stock Name Sequent Scientific Ltd ₹238.73 (-0.37%) M. Cap (Cr) 60.39 1 Yr Return (%) +23.97% P/E (TTM) 134.64 PB Ratio 8.88
Stock Name Supriya Lifescience Ltd ₹743.10 (-3.84%) M. Cap (Cr) 59.81 1 Yr Return (%) +5.64% P/E (TTM) 32.79 PB Ratio 6.60
Stock Name Zota Health Care Ltd ₹1685.10 (+0.92%) M. Cap (Cr) 51.11 1 Yr Return (%) +207.61% P/E (TTM) -84.18 PB Ratio 32.04
Stock Name Gujarat Themis Biosyn Ltd ₹412.70 (-2.40%) M. Cap (Cr) 44.97 1 Yr Return (%) +28.32% P/E (TTM) 93.12 PB Ratio 20.13
Stock Name Sun Pharma Advanced Research Company Ltd ₹136.01 (-1.48%) M. Cap (Cr) 44.14 1 Yr Return (%) -28.54% P/E (TTM) -16.53 PB Ratio -57.04
Stock Name Orchid Pharma Ltd ₹866.40 (-0.38%) M. Cap (Cr) 43.94 1 Yr Return (%) -41.36% P/E (TTM) 84.09 PB Ratio 3.59
Stock Name Innova Captab Ltd ₹759.45 (+3.73%) M. Cap (Cr) 43.46 1 Yr Return (%) -21.61% P/E (TTM) 34.92 PB Ratio 4.53
Gujarat Themis Biosyn Ltd Cash Flow
Cash flow data provides a view of how money is generated and spent by Gujarat Themis Biosyn Ltd, across its operating activities, investing activities, and financing activities.
PARTICULARS Operating Activities Mar 2025 91.03 Mar 2024 64.21
PARTICULARS Investing Activities Mar 2025 -111.82 Mar 2024 -55.21
PARTICULARS Financing Activities Mar 2025 26.01 Mar 2024 -8.59
PARTICULARS Net Cash Flow Mar 2025 5.22 Mar 2024 0.41
Gujarat Themis Biosyn Ltd Shareholding Pattern
This shows the ownership breakdown of Gujarat Themis Biosyn Ltd, highlighting participation from Foreign Institutional Investors (FII), Mutual Funds, Public, Other Institutions, and Promoters.
Promoter 70.86%
Public 25.01%
Other Institutions 0.01%
FII 2.95%
Mutual Funds 1.16%
About Gujarat Themis Biosyn Ltd
Promoted byJayshree D Patel, Gujarat Themis Biosyn Limited (GTBL) was incorporated in 1981 as a joint sector company with Gujarat Industrial Investment Corporation Ltd (GIIC) and Chemosyn (P) Ltd. The Company commenced production in August 1985. It was subsequently taken over in June 1991 by Yuhan Group, South Korea and Pharmaceutical Business Group (India) Ltd. (PBG); a unique consortium of five competing drug companies - Themis Medicare Ltd., Kopran Ltd., Anant & Co., Cadila Health Care Ltd. (Zydus) and Lyka Labs Ltd. It is actively managed by Themis Medicare Ltd. (JV company of Gedeon Richter Ltd, Hungary) since 2007.Initially manufacturing the antibiotic, erythromycin, GTBL obtained licences to manufacture bulk drugs like rifampicin, cephalexin, griseofulvin and their formulations in 1990. However, problems relating to purity levels, yield and imports put the company in the red and it became a BIFR case in 1990. Subsequently, Company was taken over by a group consisting of Lyka Labs, Themis Chemicals, Kopran and Cadila. Also, Yuhan Corp., South Korea, brought in technology and finance for running GTBL.During 1995-96 the paid-up share capital increased from Rs 11.25 crores to Rs 11.60 crores after allotment of 350,000 Equity shares of Rs 10 each at a premium of Rs 20 per share to the financial institutions by way of conversion of fund interst term loan. During the year 2019-20, installed capacity of rifamysin-S was increased to 90 mtpa and expansion of rifampicin was achieved to the maximum capacity of 120 mtpa. It also commenced operations of its new pharmaceutical division and launched a wide range of anti-tuberculosis products and other antibiotics in 2022.Company is presently engaged in the manufacturing of fermentation-based pharmaceutical intermediates and APIs. It is manufacturing Rifamycin S, which is an intermediate for manufacturing the drug Rifampicin and Rifamycin O, which is an intermediate for manufacturing the drug Rifaximin. The Company commenced its commercial production at its newly set up API Plant situated at 69/C, GIDC Industrial Estate, Vapi, in Valsad district of Gujarat with effect from 6 May, 2025. The multi-purpose synthetic and fermentation-based API plant has been established for the production of various Active Pharmaceutical Ingredients (APIs) and Intermediates for use in the pharmaceutical industry.
Chairman & Non Executive Dir.
Dinesh S Patel
Registered office 69/C GIDC Industrial Estate, Valsad Dist, VAPI, Gujarat, 396195
FAX :91-260-2430027
Background
Incorporation Year 1981
Face Value ₹1.00
Market Lot 1
FAQs on Gujarat Themis Biosyn Ltd
How to buy Gujarat Themis Biosyn Ltd shares on NSE?
To buy Gujarat Themis Biosyn Ltd shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified.
What is the Gujarat Themis Biosyn Ltd share price today?
The Gujarat Themis Biosyn Ltd share price on NSE is ₹412.70 today.
What is the market cap of Gujarat Themis Biosyn Ltd on NSE?
The company has a market capitalization of ₹4497.
What is the PE & PB ratio of Gujarat Themis Biosyn Ltd?
PE is 93 and PB is 4.
What is the 52 Week High and Low of Gujarat Themis Biosyn Ltd shares?
Gujarat Themis Biosyn Ltd stock price high: ₹479 Gujarat Themis Biosyn Ltd stock price low: ₹208.